Koganemaru, S., Han, J., Buckley, S., Kaneko, N., Ohue, Y., Toso, J. F., Yamamoto, N. (2026). A phase 1, first-in-human study of DS3610, a stimulator of interferon genes (STING) agonist antibody-drug conjugate (ADC), in patients with advanced/metastatic solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3159